News | August 28, 2007

EndoGastric Solutions Raises $30 Million to Fund U.S. Commercialization

August 29, 2007 — EndoGastric Solutions, a leader in natural orifice surgery (NOS), announced it has completed a $30 million round of private financing to fund expansion of sales in the U.S. of the StomaphyX device, cleared for U.S. sales in March, and the anticipated launch of its EsophyX device later in 2007.
The financing, EndoGastric Solutions' Series D Round, was led by DeNovo Ventures of Palo Alto, CA. In connection with the financing, Joe Mandato of DeNovo Ventures will join the company's Board of Directors.
In addition to the new lead investor, the company's existing investors including Chicago Growth Partners, MPM Capital, Advanced Technology Ventures, Foundation Medical Partners, and Oakwood Medical Investors also participated in the financing.
"We are delighted to have the support of a sophisticated investor group like De Novo,” said Thierry Thaure, EndoGastric Solutions' president and CEO. “Their team brings a unique depth of industry experience to bear on the exciting challenges that face EndoGastric Solutions in the upcoming quarters as we transition out of pure new product development and clinical trial phases and into building a solid customer base with U.S. and international product revenues."
"We believe that EndoGastric Solutions is ahead of other companies in this space,” said Joe Mandato of DeNovo. “The combination of technological know-how, product portfolio, the large underserved targeted population together with the experience of its management team makes EGS an attractive investment opportunity. EGS' innovative products provide significant benefits to patients because, unlike laparoscopic or open surgical procedures, they allow for incision-less, less-invasive and less-time consuming procedures."

For more information: www.endogastricsolutions.com.

Related Content

Image courtesy of Philips Healthcare

News | Clinical Trials | July 19, 2018
The use of computed tomography (CT) scans has increased dramatically over the last two decades. CT scans greatly...
CT Decision Instrument Reliably Guides Pediatric Blunt Trauma imaging Decisions

This is a four-site prospective observational cohort. Image courtesy of Kirsty Challen, B.Sc., MBCHB, MRES, Ph.D., Lancashire Teaching Hospitals, United Kingdom.

News | Clinical Decision Support | July 18, 2018
A new study finds The Pediatric NEXUS Head Computed Tomography (CT) Decision Instrument (DI) reliably identifies blunt...
Study Shows Biomarker Panel Boosts Lung Cancer Risk Assessment for Smokers
News | Lung Cancer | July 16, 2018
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon...
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
IAC Awards First CT Accreditation for a Mobile Stroke Unit
News | Computed Tomography (CT) | July 09, 2018
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center...
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | Computed Tomography (CT) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Peter Juodka, RT(CT) operates the 16-slice Siemens Somatom Scope CT scanner in the mobile stroke unit to assess stroke patients immediately at the call site.

Peter Juodka, RT(CT) operates the 16-slice Siemens Somatom Scope CT scanner in the mobile stroke unit to assess stroke patients immediately at the call site.

Feature | Computed Tomography (CT) | July 03, 2018 | By Jeff Zagoudis
Stroke is the fifth leading cause of death in the United States, responsible for more than 140,000 deaths in some of
Neusoft Medical Systems USA Introducing NeuViz 16 Essence CT at AHRA 2018
Technology | Computed Tomography (CT) | June 27, 2018
At the 2018 Association for Medical Imaging Management (AHRA) Annual Meeting, July 22-25 in Orlando, Fla., Neusoft...
Overlay Init